Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

Taylor-Rowan, MartinKraia, OlgaKolliopoulou, ChristinaCross, Amanda J.Stewart, CarrieMyint, Phyo KyawMcCleery, JennyQuinn, Terry J2022-11-182022-11-182022-08-22Taylor-Rowan, M, Kraia, O, Kolliopoulou, C, Cross, A J, Stewart, C, Myint, P K, McCleery, J & Quinn, T J 2022, 'Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.', Cochrane Database of Systematic Reviews, vol. 2021, no. 11, CD015196. https://doi.org/10.1002/14651858.CD015196, https://doi.org/10.1002/14651858.CD015196.pub21469-493XORCID: /0000-0003-3852-6158/work/163198714https://hdl.handle.net/2164/19561Acknowledgements We would like to thank Dr Kate Wang, Dr Andrew Stafford, Ms Catherine Hofstetter, and Dr Joanna Damen for their helpful peer review comments on this protocol.19188867188867engR MedicineRAnticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.Journal article10.1002/14651858.CD01519611